Estimating asymptomatic SARS-CoV-2 infections in a geographic area of low disease incidence.
Asymptomatic individuals
Covid-19
Disease prevalence
IgG
SARS-CoV-2
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
15 Apr 2021
15 Apr 2021
Historique:
received:
29
01
2021
accepted:
05
04
2021
entrez:
15
4
2021
pubmed:
16
4
2021
medline:
22
4
2021
Statut:
epublish
Résumé
The SARS-CoV-2 infection has emerged as a rapidly spreading infection. Today it is relatively easy to isolate Covid-19 symptomatic cases, while remains problematic to control the disease spread by infected but symptom-free individuals. The control of this possible path of contagion requires drastic measures of social distancing, which imply the suspension of most activities and generate economic and social issues. This study is aimed at estimating the percentage of asymptomatic SARS-CoV-2 infection in a geographic area with relatively low incidence of Covid-19. Blood serum samples from 388 healthy volunteers were analyzed for the presence of anti-SARS-CoV-2 IgG by using an ELISA assay based on recombinant viral nucleocapsid protein. We found that 7 out of 388 healthy volunteers, who declared no symptoms of Covid-19, like fever, cough, fatigue etc., in the preceding 5 months, have bona fide serum anti-SARS-CoV-2 IgG, that is 1.8% of the asymptomatic population (95% confidence interval: 0.69-2.91%). The estimated range of asymptomatic individuals with anti-SARS-CoV-2 IgG should be between 26,565 and 112, 350. In the same geographic area, there are 4665 symptomatic diagnosed cases.
Sections du résumé
BACKGROUND
BACKGROUND
The SARS-CoV-2 infection has emerged as a rapidly spreading infection. Today it is relatively easy to isolate Covid-19 symptomatic cases, while remains problematic to control the disease spread by infected but symptom-free individuals. The control of this possible path of contagion requires drastic measures of social distancing, which imply the suspension of most activities and generate economic and social issues. This study is aimed at estimating the percentage of asymptomatic SARS-CoV-2 infection in a geographic area with relatively low incidence of Covid-19.
METHODS
METHODS
Blood serum samples from 388 healthy volunteers were analyzed for the presence of anti-SARS-CoV-2 IgG by using an ELISA assay based on recombinant viral nucleocapsid protein.
RESULTS
RESULTS
We found that 7 out of 388 healthy volunteers, who declared no symptoms of Covid-19, like fever, cough, fatigue etc., in the preceding 5 months, have bona fide serum anti-SARS-CoV-2 IgG, that is 1.8% of the asymptomatic population (95% confidence interval: 0.69-2.91%).
CONCLUSIONS
CONCLUSIONS
The estimated range of asymptomatic individuals with anti-SARS-CoV-2 IgG should be between 26,565 and 112, 350. In the same geographic area, there are 4665 symptomatic diagnosed cases.
Identifiants
pubmed: 33853532
doi: 10.1186/s12879-021-06054-2
pii: 10.1186/s12879-021-06054-2
pmc: PMC8046491
doi:
Substances chimiques
Antibodies, Viral
0
Immunoglobulin G
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
350Références
J Infect Dev Ctries. 2020 May 31;14(5):440-446
pubmed: 32525828
J Med Virol. 2021 Mar;93(3):1739-1742
pubmed: 32790086
Internist (Berl). 2020 Aug;61(8):782-788
pubmed: 32548652
Future Sci OA. 2021 Jan 12;7(4):FSO673
pubmed: 33815819
Lancet Infect Dis. 2020 Jul;20(7):758-759
pubmed: 32330441
Appl Health Econ Health Policy. 2020 Aug;18(4):509-517
pubmed: 32495067
Nature. 2020 Jan;577(7792):605-607
pubmed: 31992880
Pathogens. 2021 Feb 03;10(2):
pubmed: 33546341
J Clin Med. 2020 Feb 04;9(2):
pubmed: 32033064
J Med Virol. 2021 Feb;93(2):803-811
pubmed: 32667733
Front Public Health. 2020 Jun 10;8:262
pubmed: 32587844
Euro Surveill. 2020 Mar;25(10):
pubmed: 32183930